Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients.

Nicholas PiccicaccoKristen ZeitlerJose MonteroAmbuj KumarSeetha LakshmiKami KimDavid WeinTiffany VaseyMatthew VaseyAsa Oxner

Published in: Open forum infectious diseases (2021)

Among high-risk COVID-19 outpatients with mild/moderate symptoms, early administration of mAbs can potentially reduce the strain on the health care system during the current pandemic.

Keyphrases

respiratory syndrome coronavirus
sars cov
coronavirus disease
monoclonal antibody
randomized controlled trial
systematic review
high intensity
physical activity